The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
FLT3 mutations in acute myeloid leukemia cell lines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S., Kashima, K., Sonoda, Y., Fujimoto, T., & Misawa, S. (1996) · PubMed · Cited by 1,162
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Yamamoto, Y. (2001) · Blood · doi:10.1182/blood.v97.8.2434 · Cited by 1,150
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 757
Whitman, S. P., Archer, K. J., Lin, F., Baldus, C. D., Becknell, B., Carlson, B. D., Carroll, A. J., Mrózek, K., Vardiman, J., George, S. L., et al. (2001) · PubMed · Cited by 633
Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Müller, C., Grüning, W., Kratz-Albers, K., Serve, S., Steur, C., et al. (2000) · Blood · doi:10.1182/blood.v96.12.3907 · Cited by 606
Hayakawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T., Saito, H., & Naoe, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203354 · Cited by 579
Meshinchi, S., Woods, W. G., Stirewalt, D. L., Sweetser, D. A., Buckley, J. D., Tjoa, T. K., Bernstein, I. D., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.1.89 · Cited by 518
Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400812 · Cited by 455
Kiyoi, H., Towatari, M., Yokota, S., Hamaguchi, M., Ohno, R., Saito, H., & Naoe, T. (1998) · Leukemia · doi:10.1038/sj.leu.2401130 · Cited by 453
Identification of novel FLT‐3 Asp835 mutations in adult acute myeloid leukaemia
Abu‐Duhier, F. M., Goodeve, A. C., Wilson, G. A., Care, R. S., Peake, I. R., & Reilly, J. T. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02850.x · Cited by 388
Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias
Carow, C., Levenstein, M., Kaufmann, S., Chen, J., Amin, S., Rockwell, P., Witte, L., Borowitz, M., Civin, C., & Small, D. (1996) · Blood · doi:10.1182/blood.v87.3.1089.bloodjournal8731089 · Cited by 345
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia
Kiyoi, H., Naoe, T., Yokota, S., Nakao, M., Minami, S., Kuriyama, K., Takeshita, A., Saito, K., Hasegawa, S., Shimodaira, S., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400756 · Cited by 344
Rombouts, W., Blokland, I., Löwenberg, B., & Ploemacher, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401731 · Cited by 277
Rosnet, O., Bühring, H. ‐., Marchetto, S., Rappold, I., Lavagna, C., Sainty, D., Arnoulet, C., Chabannon, C., Kanz, L., Hannum, C. H., et al. (1996) · PubMed · Cited by 245
Birg, F., Courcoul, M., Rosnet, O., Bardin, F., Pebusque, M., Marchetto, S., Tabilio, A., Mannoni, P., & Birnbaum, D. (1992) · Blood · doi:10.1182/blood.v80.10.2584.2584 · Cited by 226
Zhang, S., Fukuda, S., Lee, Y., Hangoc, G., Cooper, S., Spolski, R., Leonard, W. J., & Broxmeyer, H. E. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.719 · Cited by 206
Tse, K.-F., Mukherjee, G., & Small, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401905 · Cited by 195
Levis, M., Tse, K.-F., Smith, B. D., Garrett, E., & Small, D. (2001) · Blood · doi:10.1182/blood.v98.3.885 · Cited by 189
Fenski, Flesch, Serve, Mizuki, Oelmann, Kratz‐Albers, Kienast, Leo, Schwartz, Berdel, et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01831.x · Cited by 146
Class III receptor tyrosine kinases: role in leukaemogenesis
Reilly, J. T. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03294.x · Cited by 143
Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts
Birkenkamp, K., Geugien, M., Lemmink, H. H., Kruijer, W., & Vellenga, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402317 · Cited by 143
Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor
Tse, K.-F., Novelli, E. M., Civin, C., Böhmer, F., & Small, D. (2001) · Leukemia · doi:10.1038/sj.leu.2402199 · Cited by 116
Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
Meierhoff, G., Dehmel, U., Gruss, H. J., Rosnet, O., Birnbaum, D., Quentmeier, H., Dirks, W. G., & Drexler, H. G. (1995) · PubMed · Cited by 110
Self-citationGenomic structure of human FLT3: implications for mutational analysis
Abu‐Duhier, F. M., Goodeve, A. C., Wilson, G. A., Care, R. S., Peake, I. R., & Reilly, J. T. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02821.x · Cited by 84
The Leukemia-Lymphoma Cell Line Factsbook
Drexler, H. G. (2000) · Thammasat University Digital Collections · Cited by 74
Self-citationThe Leukemia-Lymphoma Cell Line FactsBook
(2001) · Elsevier eBooks · doi:10.1016/b978-0-12-221970-2.x5000-1 · Cited by 52
Srinivasa, S. P., & Doshi, P. D. (2002) · Leukemia · doi:10.1038/sj.leu.2402367 · Cited by 51
Stacchini, A., Fubini, L., Severino, A., Sanavio, F., Aglietta, M., & Piacibello, W. (1996) · PubMed · Cited by 49
Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
Dehmel, U., Zaborski, M., Meierhoff, G., Rosnet, O., Birnbaum, D., Ludwig, W. D., Quentmeier, H., & Drexler, H. G. (1996) · PubMed · Cited by 44
Self-citationDirks, W. G., MacLeod, R. A. F., Jäger, K., Milch, H., & Drexler, H. G. (1999) · PubMed · Cited by 34
Self-citationBeslu, N., LaRose, J., Castéran, N., Birnbaum, D., Lecocq, E., Dubreuil, P. C., & Rottapel, R. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20075 · Cited by 33
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Zarrinkar, P. P., Gunawardane, R. N., Cramer, M. D., Gardner, M. F., Brigham, D., Belli, B., Karaman, M. W., Pratz, K. W., Pallares, G., Chao, Q., et al. (2009) · Blood · doi:10.1182/blood-2009-05-222034 · Cited by 634
Wang, T., Yu, H., Hughes, N. W., Liu, B., Kendirli, A., Klein, K., Chen, W. W., Lander, E. S., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.01.013 · Cited by 632
“Four of the cell lines carry activating mutations in FLT3, an established oncogene in AML; while FLT3 scored as an essential gene in three of these, it did not in PL-21 cells, which were also insensitive to quizartinib, a FLT3 inhibitor (Figures 4A and S4A) (Quentmeier et al., 2003).”
BackgroundFLT3: ITDoes matter in leukemia
Levis, M., & Small, D. (2003) · Leukemia · doi:10.1038/sj.leu.2403099 · Cited by 495
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Huang, H.-T., Dobrovolsky, D., Paulk, J., Yang, G., Weisberg, E. L., Doctor, Z. M., Buckley, D. L., Cho, J.-H., Ko, E., Jang, J., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.005 · Cited by 437
Metadata
- Authors
- Quentmeier, H., Reinhardt, J., Zaborski, M., & Drexler, H. G.
- Venue
- Leukemia
- Published
- 2003-01-01
- Volume
- 17
- Issue
- 1
- Pages
- 120-124
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2165392081
- Cited by
- 283
- References
- 31
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.